This is to inform you that the Earnings Conference Call for investors and analysts has been scheduled for Thursday, October 28, 2026, at 3:30 p.m. (IST) to discuss the Company''s Q2-FY27 Financial Results

October 22, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE LTD. National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block, Bandra Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 SCRIP CODE: 543748 SYMBOL: AARTIPHARM Dear Sir/Madam, Sub: Intimation of Earnings Conference Call Ref: Regulation 30 of the SEBI (LODR) Regulations, 2015 This is to inform you that the Earnings Conference Call for investors and analysts has been scheduled for Thursday, October 29, 2026, at 3:30 P.M. (IST) to discuss the Company’s Q2 FY27 financial results. Please find attached herewith Invitation for the same. Kindly take the same on your record. Thanking you, Yours faithfully, For AARTI PHARMALABS LIMITED JEEVAN MONDKAR COMPANY SECRETARY AND LEGAL HEAD ICSI M. NO. A22565 Encl. a/a. Conference Call Invitation AARTI Q2 & H1FY27 Earnings Call PRIVATE CLIENT GROUP PHARMALABS PhillipCapital (India) Private Limited cordially invites you to participate in Aarti Pharmalabs Ltd. Q2 & H1FY27 Earnings conference call to discuss operational and financial performance Speakers NSE: AARTIPHARM | ISIN CODE: INE0LRU01027 Mr. Rashesh Gogri – Managing Director BLOOMBERG: AARTIPHA IN Mr. Piyush Lakhani – Chief Financial Officer Mrs. Hetal Gogri Gala – Executive Director Thursday – 29th October 2026 @ 03:30 PM IST Call Leader 06:00 PM Singapore & HK / 10:00 AM UK Mr. Apurva Shah / Mr. Om Sanghavi Pre-register to avoid wait time, join with DiamondPass Click Here to register Dial-In-Numbers Primary Number: +91 22 6280 1143/+91 22 7115 8044 The numbers listed above is universally accessible from all networks and all countries. Toll Free Number: USA: 18667462133 / UK: 08081011573 / Singapore: 8001012045 / Hong Kong: 800964448 #PhillipCapital (India) Private Limited remains committed to adhere to all regulatory guidelines and follow the best governance and transparency practices. Therefore: •The proceedings of this call will be recorded. •The list and full details of participants on the call will be shared by us with the corporate. Participants are expected to provide true and legitimate details. •All necessary disclosures on Stock Exchanges (including call invite intimation, recording details & call transcript) is expected to be complied by the respective corporate.